Up-regulation of CNDP2 facilitates the proliferation of colon cancer

BMC Gastroenterology

Research Article

Mingyong Miao¹  Zhenwei Zhang¹  Ting Yang²  Hanping Shi³  Miao Yu³  Conglong Xue³  Honglan Yu³  Kaitao Yuan³ 

[1] Department of Biochemistry and Molecular Biology, Second Military Medical University, 800 Xiangyin Road, 200433, Shanghai, China;Department of Intensive Care Unit, Zhongshan people’s Hospital, 2 Sunwen East Road, 528403, Zhongshan, Guangdong, China;Department of Surgery, The First Affiliated Hospital, Sun Yat-sen University, 58 Zhongshan II Road, 510080, Guangzhou, Guangdong, China;

关键词: CNDP2;    Colon cancer;    Poliferation;    Clinicopathological Characteristics;    RNA interference;   

DOI  :  10.1186/1471-230X-14-96

 received in 2013-07-24, accepted in 2014-05-14,  发布年份 2014

来源: Springer

【 摘 要 】

BackgroundCytosolic nonspecific dipetidase (CN2) belongs to the family of M20 metallopeptidases. It was stated in previous articles that higher expression levels of CN2 were observed in renal cell carcinoma and breast cancer. Our study explored the correlation between CN2 and colon carcinogenesis.MethodsWe analysed the relationship between 183 patients clinicopathological characteristics and its CN2 expression. To detect the levels of CN2 in colon cancer cell lines and colon cancer tissues by western blot. To verify cell proliferation in colon cancer cells with knockdown of CNDP2 and explore the causes of these phenomena.ResultsThe expression levels of CN2 in clinical colon tumors and colon cancer cell lines were significantly higher than that in normal colon mucosa and colon cell lines. The difference in CN2 levels was associated with tumor location (right- and left-sided colon cancer), but there was no significant association with age, gender, tumor size, tumor grade, tumor stage or serum carcinoembryonic antigen (CEA). Knockdown of CNDP2 inhibited cell proliferation, blocked cell cycle progression and retarded carcinogenesis in an animal model. The signaling pathway through which knockdown of CNDP2 inhibited cell proliferation and tumorigenesis involved in EGFR, cyclin B1 and cyclin E.ConclusionsKnockdown of CNDP2 can inhibit the proliferation of colon cancer in vitro and retarded carcinogenesis in vivo.

【 授权许可】

Unknown   
© Xue et al.; licensee BioMed Central Ltd. 2014. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.